O
Oishimaya Sen
Researcher at Bose Corporation
Publications - 5
Citations - 163
Oishimaya Sen is an academic researcher from Bose Corporation. The author has contributed to research in topics: Viability assay & Mitochondrial permeability transition pore. The author has an hindex of 5, co-authored 5 publications receiving 136 citations.
Papers
More filters
Journal ArticleDOI
α‐synuclein‐induced mitochondrial dysfunction in isolated preparation and intact cells: Implications in the pathogenesis of Parkinson's disease
Aritri Bir,Oishimaya Sen,Shruti Anand,Vineet Kumar Khemka,Priyanjalee Banerjee,Roberto Cappai,Arghyadip Sahoo,Sasanka Chakrabarti +7 more
TL;DR: It is suggested that intracellularly accumulated α‐synuclein can interact with mitochondria in intact SHSY5Y cells causing dysfunction of the organelle which drives the cell death under the authors' experimental conditions, which has clear implications in the pathogenesis of sporadic Parkinson's disease.
Journal ArticleDOI
Dopamine Cytotoxicity Involves Both Oxidative and Nonoxidative Pathways in SH-SY5Y Cells: Potential Role of Alpha-Synuclein Overexpression and Proteasomal Inhibition in the Etiopathogenesis of Parkinson's Disease.
Kalpita Banerjee,Soumyabrata Munshi,Oishimaya Sen,Vishmadeb Pramanik,Tapasi Roy Mukherjee,Sasanka Chakrabarti +5 more
TL;DR: DA cytotoxicity includes both oxidative and nonoxidative modes and may involve overexpression and accumulation of alpha-synuclein as well as proteasomal inhibition.
Journal ArticleDOI
Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus.
Vineet Kumar Khemka,Debajit Bagchi,Arindam Ghosh,Oishimaya Sen,Aritri Bir,Sasanka Chakrabarti,Anindita Banerjee +6 more
TL;DR: Higher serum ADA, triglycerides (TG) and fasting plasma glucose (FPG) levels in nonobese T2DM patients, and a strong correlation betweenADA and FPG which suggests an association between ADA and nonobesity T2 DM subjects are shown.
Journal ArticleDOI
Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease.
Upasana Ganguly,Anindita Banerjee,Sankha Shubhra Chakrabarti,Upinder Kaur,Oishimaya Sen,Roberto Cappai,Sasanka Chakrabarti +6 more
TL;DR: It is demonstrated that iron causes an increase in α-synuclein content in SH-SY5Y cells associated with mitochondrial depolarization, decreased cellular ATP content and loss of cell viability during incubation up to 96 h, and knocking-down α- synuclein expression prevents cytotoxic actions of iron.
Journal ArticleDOI
Dopamine Cytotoxicity on SH-SY5Y Cells: Involvement of α-Synuclein and Relevance in the Neurodegeneration of Sporadic Parkinson’s Disease
Upasana Ganguly,Anirban Ganguly,Oishimaya Sen,Gargi Ganguly,Roberto Cappai,Arghyadip Sahoo,Sasanka Chakrabarti +6 more
TL;DR: Dopamine-induced mitochondrial dysfunction and the loss of cell viability under experimental conditions could be prevented by cyclosporine, a blocker of mitochondrial permeability transition pore, as well as the antioxidant N-acetylcysteine, and the dopamine effects on cell viability and mitochondrial functions were significantly prevented by knocking down α-synuclein expression by specific siRNA.